Sclerostin deficiency is linked to altered bone composition.

Area of Science:

• Biomineralization
• Skeletal Biology
• Bone Histology

Background:

• High bone mass in sclerostin deficiency is linked to increased bone strength, unlike other high bone density conditions.
• Bone composition, not just density, influences bone strength and fracture risk.

Purpose of the Study:

• To investigate if altered bone composition contributes to the enhanced bone strength observed in sclerostin deficiency.
• To compare bone composition in Sost-knockout mice and sclerosteosis patients with controls.

Main Methods:

• Quantitative backscattered electron imaging and Raman microspectroscopy were used.
• Cortical bone from Sost-knockout mice and sclerosteosis patients was analyzed.
• Bone samples were compared to wild-type mice and healthy human subjects.

Main Results:

• Endocortical bone in Sost-knockout mice showed reduced matrix mineralization and increased proteoglycan content.
• Sclerosteosis patient bone samples also exhibited lower matrix mineralization and higher proteoglycan levels.
• Mineralization heterogeneity increased in young sclerosteosis patients.

Conclusions:

• Sclerostin deficiency is associated with decreased bone matrix mineralization and increased proteoglycan content in specific bone subcompartments.
• These compositional changes are observed in both mouse models and human patients.
• Altered bone composition is hypothesized to contribute to the increased bone strength in sclerostin deficiency.